Fibrous Microcapsule Assembly via Nebulization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assembling peptide amphiphiles and biopolymers into fibrous microcapsules face challenges in producing uniform, small-scale microcapsules with controlled self-assembly and payload encapsulation for biomedical applications.
Innovation Solution
A method involving the nebulization of biopolymer micordroplets into an aqueous peptide amphiphile solution, using a pressure microinjector and glass capillary with compressed gas, to spontaneously form fibrous microcapsules with diameters less than 100 μm and a low coefficient of variation, allowing for encapsulation of proteins, small molecules, and therapeutics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to assemble peptide amphiphiles and biopolymers, then microcapsules can be formed, but uniformity and size control (manufacturing precision) are poor
Solution Approach 1:
The invention segments the microcapsule formation process into distinct stages: (1) formation of biopolymer microdroplets via nebulization, (2) self-assembly of peptide amphiphiles at the droplet interface, and (3) maturation into fibrous microcapsules. This segmentation allows precise control over each stage, particularly the nebulization parameters that determine initial droplet size and distribution, thereby achieving uniform microcapsule formation.
Solution Approach 2:
The invention performs preliminary action by pre-forming biopolymer microdroplets with controlled size distribution before introducing peptide amphiphiles. The nebulization process is optimized in advance to create uniform droplets, which then serve as templates for subsequent self-assembly. This preliminary structuring ensures that the final microcapsules inherit the size uniformity of the precursor droplets.
2Adaptability or versatility
If microcapsule size is reduced below 100 μm, then targeted delivery capability is improved, but manufacturing precision becomes more difficult to achieve
Solution Approach 1:
The invention employs pneumatic nebulization using compressed gas to fragment biopolymer solution into microdroplets. By controlling gas pressure, flow rate, and nozzle geometry, the system achieves precise control over droplet size distribution. This pneumatic approach is particularly effective for producing sub-100 μm droplets with narrow size distributions, overcoming the difficulty of manufacturing precision at small scales.
Solution Approach 2:
The invention systematically optimizes multiple parameters including biopolymer concentration, nebulization gas pressure, droplet residence time, and peptide amphiphile concentration to achieve uniform microcapsule formation at small sizes. By changing these parameters, the system maintains manufacturing precision even at microcapsule diameters below 100 μm, enabling targeted delivery applications.
3Productivity
If fibrous microcapsules are produced with low coefficient of variation, then payload encapsulation efficiency is improved, but device complexity increases
Solution Approach 1:
The invention employs self-service by utilizing the inherent self-assembly properties of peptide amphiphiles at the biopolymer droplet interface. The peptide amphiphiles automatically organize into fibrous structures without requiring external manipulation or complex processing. This self-assembly mechanism simplifies the overall device while enabling high payload encapsulation efficiency through uniform microcapsule formation.
Solution Approach 2:
The invention uses the biopolymer microdroplet as an intermediary that facilitates peptide amphiphile self-assembly. The droplet serves as a confined reaction chamber where peptide amphiphiles can spontaneously assemble into fibrous microcapsules. This intermediary approach allows simple nebulization equipment to produce uniform microcapsules with high encapsulation efficiency, avoiding the need for complex assembly devices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of uniform fibrous microcapsules with controlled size and shape, facilitating efficient encapsulation and release of payloads, suitable for biomedical applications such as targeted drug delivery and controlled release systems.
Implementation Method 1
PAs and oppositely charged polymers can self-assemble at the aqueous interface of two solutions into hierarchically organized, semipermeable membranes, producing sac-like structures on the macro scale
Implementation Method 2
producing nebulized biopolymer micordroplets
Implementation Method 3
pressure microinjector provides delivery of biopolymer
Implementation Method 4
Peptide amphiphiles assemble into high-aspect ratio nanofibers upon electrostatic screening of the charged amino acids
Data Source
AI summary
The present invention relates to assembly of peptide amphiphiles and biopolymers into fibrous microcapsules, and uses thereof. In particular, the present invention provides devices, compositions, and methods for interfacial self-assembly of peptide amphiphiles and biopolyments into fibrous microcapsules, and uses thereof.